Invanz and Zoledronic acid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Invanz (ertapenem sodium) and Zoledronic acid (zoledronic acid). Common drug interactions include sepsis among males.

The phase IV clinical study analyzes what interactions people have when they take Invanz and Zoledronic acid. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Invanz?

Invanz has active ingredients of ertapenem sodium. It is often used in urinary tract infection. eHealthMe is studying from 3,961 Invanz users. Check the latest studies of Invanz.

What is Zoledronic acid?

Zoledronic acid has active ingredients of zoledronic acid. eHealthMe is studying from 28,485 Zoledronic acid users. Check the latest studies of Zoledronic acid.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 20, 2026

19 people who take Invanz and Zoledronic acid together, and have interactions are studied.

Invanz and Zoledronic acid drug interactions.

What are the common drug interactions of Invanz and Zoledronic Acid, by gender? *:

female:

n/a

male:

Sepsis (a severe blood infection that can lead to organ failure and death)
Colorectal cancer (colon cancer or bowel cancer)
Bradycardia (abnormally slow heart action)
Enterococcal infection
Hypoglycaemia (deficiency of glucose in the bloodstream)
Palpitations (feelings or sensations that your heart is pounding or racing)
Pneumonia fungal
Renal failure acute (rapid kidney dysfunction)
Venoocclusive disease (small veins in the liver are obstructed)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

What are the common drug interactions of Invanz and Zoledronic Acid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Chest pain
Fluid overload (too much fluid in the blood)
Hypotension (abnormally low blood pressure)
Left ventricular dysfunction
Mitral valve incompetence (inefficient heart valve)
Nausea (feeling of having an urge to vomit)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Pneumonia
Pulmonary congestion (congestion in the lungs)

60+:

Sepsis (a severe blood infection that can lead to organ failure and death)
Colorectal cancer (colon cancer or bowel cancer)
Enterococcal infection
Hypoglycaemia (deficiency of glucose in the bloodstream)
Palpitations (feelings or sensations that your heart is pounding or racing)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Pneumonia fungal
Renal failure acute (rapid kidney dysfunction)
Venoocclusive disease (small veins in the liver are obstructed)
Haematochezia (passage of stools containing blood)

What are the existing conditions these people have? *

Prostate Cancer Metastatic: 13 people, 68.42%
Nausea (feeling of having an urge to vomit): 13 people, 68.42%
Infection: 11 people, 57.89%
Fever: 11 people, 57.89%
Abdominal Pain: 11 people, 57.89%
Multiple Myeloma (cancer of the plasma cells): 6 people, 31.58%
Pain: 2 people, 10.53%
Discomfort: 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Invanz and Zoledronic acid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously